What it is
CJC-1295 without DAC (drug affinity complex, an add-on that keeps the other form in the blood for days), also called Mod GRF 1-29, is a modified piece of GHRH, the hormone that tells the pituitary to release growth hormone. Four swapped amino acids make it more resistant than natural GHRH to the enzymes that break it down. It acts on the same receptor.
What makes it distinct
It shares a name with a different drug, CJC-1295 with DAC, which lasts for days in the body. That's why Tidepath always asks when you enter just "CJC-1295". The clear names are Mod GRF 1-29 for this one and CJC-1295 DAC for the other. The FDA says it has identified serious health problems (serious adverse events) linked to CJC-1295. They include a faster heart rate and blood vessels widening throughout the body (systemic vasodilatory reaction). Its note doesn't say where it found them, or which form of CJC-1295 it means. It also says compounded CJC-1295 (mixed from its ingredients by a pharmacist or doctor) given certain ways may carry a risk of immune reactions (immunogenicity). It adds that impurities related to the peptide, and checking what the ingredient is, may be complicated, and that clinical data are limited.
Open questions
- How long this form lasts in the body (pharmacokinetics). We found no study in people that reports a half-life (the time it takes for half a dose to clear) for it, and a 2026 review found none reported either. Tidepath doesn't chart its levels.
- Whether it builds muscle, alone or paired with a peptide like ipamorelin. Human studies haven't proven that it does.
More in Growth-hormone peptides